These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3002250)

  • 1. Problems of herpes simplex virus latency.
    Klein RJ
    Antiviral Res; 1985; Suppl 1():111-20. PubMed ID: 3002250
    [No Abstract]   [Full Text] [Related]  

  • 2. An inquiry into the mechanisms of herpes simplex virus latency.
    Roizman B; Sears AE
    Annu Rev Microbiol; 1987; 41():543-71. PubMed ID: 2825588
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
    Klein RJ
    Am J Med; 1982 Jul; 73(1A):138-42. PubMed ID: 6285703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal control of herpes simplex virus latency.
    Tenser RB; Edris WA; Hay KA
    Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of acute, latent and recurrent herpes simplex virus infections.
    Klein RJ
    Arch Virol; 1982; 72(3):143-68. PubMed ID: 6180702
    [No Abstract]   [Full Text] [Related]  

  • 6. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.
    Coen DM; Kosz-Vnenchak M; Jacobson JG; Leib DA; Bogard CL; Schaffer PA; Tyler KL; Knipe DM
    Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4736-40. PubMed ID: 2543985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus latency.
    Hill TJ; Altmann DM; Blyth WA; Harbour DA; Whitby A
    Clin Dermatol; 1984; 2(2):46-55. PubMed ID: 6100716
    [No Abstract]   [Full Text] [Related]  

  • 8. Virus-drug resistance: thymidine kinase-deficient (TK-) mutants of herpes simplex virus. Therapeutic approaches.
    de Clercq E
    Ann Ist Super Sanita; 1987; 23(4):841-7. PubMed ID: 2837935
    [No Abstract]   [Full Text] [Related]  

  • 9. [Latency of herpes simplex virus. Current knowledge].
    Catalán V; Gimeno C; García-de-Lomas J
    Enferm Infecc Microbiol Clin; 1991 Mar; 9(3):172-6. PubMed ID: 1650583
    [No Abstract]   [Full Text] [Related]  

  • 10. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus drug-resistance: mechanisms and consequences.
    Larder BA; Darby G
    Antiviral Res; 1984 Apr; 4(1-2):1-42. PubMed ID: 6331303
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of thymidine kinase-negative herpes simplex virus to reactivate from latency following efficient establishment.
    Chen SH; Pearson A; Coen DM; Chen SH
    J Virol; 2004 Jan; 78(1):520-3. PubMed ID: 14671133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-galactosidase as a marker in the peripheral and neural tissues of the herpes simplex virus-infected mouse.
    Ho DY; Mocarski ES
    Virology; 1988 Nov; 167(1):279-83. PubMed ID: 2847416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation.
    Fraser NW; Valyi-Nagy T
    Microb Pathog; 1993 Aug; 15(2):83-91. PubMed ID: 8255209
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of latent infections in mice inoculated with herpes simplex virus which is clinically resistant to acyclovir.
    Field HJ; Lay E
    Antiviral Res; 1984 Apr; 4(1-2):43-52. PubMed ID: 6331304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of bromovinyldeoxyuridine-resistant strains of herpes simplex virus and successful chemotherapy of mice infected with one such strain by using acyclovir.
    Field HJ; Neden J
    Antiviral Res; 1982 Oct; 2(5):243-54. PubMed ID: 6295272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance and latency.
    Field HJ
    Br Med Bull; 1985 Oct; 41(4):345-50. PubMed ID: 2996685
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum.
    Levin MJ; Weinberg A; Leary JJ; Sarisky RT
    Pediatr Infect Dis J; 2001 Nov; 20(11):1094-7. PubMed ID: 11734722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpes simplex virus infections.
    Reichman RC
    Eur J Clin Microbiol; 1984 Oct; 3(5):399-405. PubMed ID: 6094187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication, latent infection, and reactivation in neuronal culture with a herpes simplex virus thymidine kinase-negative mutant.
    Wilcox CL; Crnic LS; Pizer LI
    Virology; 1992 Mar; 187(1):348-52. PubMed ID: 1310559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.